The frozen food giant announces a steady quarterly payout, with analysts highlighting a sustainable yield but tempered expectations for future dividend hikes.
A major advisory firm's complete exit from a short-term Treasury ETF is sparking debate on whether institutional investors are moving idle cash into higher-growth opportunities.
While the STOXX Europe 600 edges higher on cautious optimism, a deep dive reveals a pool of fundamentally strong companies trading significantly below their estimated intrinsic value, presenting potential opportunities for discerning investors.
A new analysis reveals a stark geographic divide in credit health, with residents in several Southern states facing higher long-term mortgage costs due to lower average credit scores, while Northern states benefit from more favorable rates.
Shares of Wolverine World Wide (NYSE: WWW) have rallied sharply in recent weeks, yet remain significantly below their intrinsic value estimate. With strong profit growth projected, analysts debate whether the market is overlooking a key turnaround story in the making.
CECO Environmental Corp. (NASDAQ: CECO) has surged in recent months, nearing its yearly high. With the mid-cap clean tech firm now trading near fair value, we analyze whether investors have missed the bargain window or if strategic entry points remain.
Pharmaceutical giant Eli Lilly announces a massive $3.5 billion investment in a new Pennsylvania manufacturing facility dedicated to next-generation weight-loss drugs, signaling a long-term strategic commitment to the obesity market amid intense competition.
SEI Investments (SEIC) has delivered impressive returns for shareholders over the past five years, but a closer look at its current valuation suggests the stock may have run ahead of its fundamentals. With shares trading near $88, analysis indicates potential overvaluation, prompting investors to weigh future growth against present price.
Merck & Co. shares have delivered impressive multi-year returns, climbing over 80% in the past five years. Yet, a deep dive into its valuation metrics suggests the market may still be underestimating the pharmaceutical leader's intrinsic value, presenting a potential opportunity for investors.
While index funds offer market-average returns, picking the right stock can yield significantly more. Itron, Inc. (NASDAQ: ITRI) has proven just that, delivering a 71% return to shareholders over the past three years—outperforming broader indices—as it transitioned to profitability. However, recent headwinds have tempered the rally, raising questions about its near-term trajectory.
U.S. stock futures retreated Monday as investors parsed a mixed bag of global manufacturing data, raising fresh questions about the durability of corporate earnings against a backdrop of cooling factory activity in key European economies.
Jim Saulnier & Associates reduced its position in the Vanguard 0-3 Month T-Bill ETF by over $5.8 million in Q4, yet short-term Treasuries remain a key liquidity component, accounting for over 5% of its portfolio.
Months after a sudden $19 billion liquidation event rocked crypto markets, a war of words has erupted among industry CEOs. The debate centers on whether the crash was caused by a technical glitch, systemic leverage, or aggressive yield marketing, exposing deep fissures in the industry's post-mortem analysis.
Global logistics firm GXO will close its Romeoville, Illinois plant this April, citing evolving business needs. The move, announced under state WARN Act requirements, eliminates 32 positions, though the company says affected workers may apply for roles at other sites.
While growth often requires investment, a sustained negative free cash flow can signal deep-seated issues. We examine three well-known companies where the cash burn warrants a cautious approach from investors.
Focused Wealth Management significantly reduced its stake in a short-term Treasury ETF, signaling a strategic pivot towards equities as stock markets reach new highs. The move highlights a broader trend of capital rotation in response to shifting risk appetites.
While small-cap stocks have broadly underperformed, recent insider buying activity points to potential value in select global companies. We examine three firms where leadership is putting their own capital to work.
Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
The alternative investment manager faces heightened scrutiny as analysts project a slowdown in revenue growth ahead of Tuesday's earnings release, despite a history of recent beats.
As Artisan Partners prepares to report fourth-quarter results, investors are weighing its recent track record against a backdrop of mixed signals from peers. Will this earnings release mark a turning point?
